Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...
Read Full News1.
Survivors of childhood brain cancer are more likely to be held back in school
2.
Trump slashed US cancer research by 31 percent: Senate report
3.
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
1.
The Benefits and Risks of Thrombolytics: A Comprehensive Guide
2.
Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development
3.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
4.
Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans
5.
Polyposis Syndrome: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
3.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC - Part III
5.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge